US 9198899
Dual-acting benzoimidazole antihypertensive agents
granted A61KA61K31/4184A61K31/4439
Quick answer
US patent 9198899 (Dual-acting benzoimidazole antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/4184, A61K31/4439, A61K31/5377, A61K45/06